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SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comleast in XIENCE with signiﬁcant difference compared to BioMatrix Flex (p< 0.001)
and Synergy (p< 0.001).
Conclusions: The current ex vivo swine shunt model demonstrated the least throm-
bogenicity in permanent polymer XIENCE as compared to 4 biodegradable polymer
DES, which emphasizes its acute protective effect against thrombus formation.TCT-437
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Background: Transcatheter mitral annuloplasty (TMA) has been introduced as
alternative to open-heart surgery. The Cardioband TMA (Valtech Cardio, Israel) is a
ﬂexible band delivered over the posterior annulus by multiple anchors. The implant
size is adjusted to reduce the annulus dimension. The aim of the study is to compare
the biomechanical impact of the Cardioband TMA vs. a surgical annuloplasty pro-
cedure (SAP) with a rigid-complete ring.
Methods: A computational model of pathological functional mitral valve (MV) was
derived from cardiac MRI, to analyse effects during systolic closure following TMA
and SAP. The TMA was simulated by placing 14 anchors (8mm spacing) in the
posterior annulus, as per device speciﬁcations. An homogeneous 33% shortening of
the device was imposed, as from clinical data. The SAP was simulated modelling the
annulus into the surgical ring shape. Closure dynamics, leaﬂets and annular conﬁg-
uration and stresses were compared.
Results: MV area was reduced from 16.0 to 7.8 and 6.5cm2 with TMA and SAP,
respectively. Coaptation length (CL) increased from 0 to 3.5 and 4.3mm respectively.
Leaﬂet and the annular peak stresses at baseline were both equal to 800kPa. Following
TMA they decreased to 250 and 500kPa, while following SAP leaﬂet stresses
decreased to 450kPa but annular stresses increased over 800kPa.B128 JACC Vol 64/11/Suppl B jConclusions: SAP was associated with slightly higher CL and reduced MV area, but
induced higher stresses on the mitral annulus. TMA resulted in an effective
improvement of valve competence while avoiding mechanical overloads. These
promising outcomes are under further clinical evaluation.
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Background: Atherosclerotic plaque rupture remains the leading cause of acute
cardiovascular syndromes and the need for plaque stabilizing interventions is high. In
the last 10 years, cryotherapy was investigated as a new technology to treat vascular
disease. Previous studies focused mainly on treatment and prevention of restenosis in
peripheral arterial disease. The efﬁciency of cryotherapy on stabilizing atherosclerotic
plaques has never been described. The purpose of the present study was to evaluate the
effect of catheter-based cryotherapy on atherosclerotic plaque composition in a rabbit
model of atherosclerosis.
Methods: Twenty-four New-Zealand White rabbits were fed a 0.3%-cholesterol
supplemented diet for 24 weeks. At three predeﬁned sites of the atherosclerotic
thoracic aorta, balloon angioplasty applying either single dose, double dose
cryotherapy or control inﬂation was performed. Rabbits were continued on
cholesterol-supplemented diet for 1 day (acute) or 4 weeks (chronic). After
euthanasia and preparation for histology, sections were analyzed for apoptosis,
content of smooth muscle cells (SMC), collagen, and macrophages, endothelium
and calciﬁcations.
Results: One day after cryotherapy, apoptotic cell death of SMCs and endothelial
cells (ECs) was observed, whereas macrophages were unaffected. Four weeks after
cryo-treatment, the amount of SMCs was restored and the EC layer was regener-
ated. Moreover, the thickness and type I collagen content of the ﬁbrous cap was
increased, indicative of a more stable plaque. The percentage of macrophages was
slightly increased in deep layers, but unaltered in luminal layers of the plaque. The
frequency of plaque calciﬁcations was increased and signs of positive remodeling
were observed.
Conclusions: For the ﬁrst time in atherosclerotic lesions, this present study demon-
strated that cryotherapy is safe and appears to stabilize atherosclerotic plaques in a
rabbit model. This warrants further investigation.
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Background: The Multilayer Flow Modulator (MFM) (Cardiatis, Isnes, Belgium) is a
self-expandable mesh of cobalt alloy wires used for the treatment of aortic aneurysms.
We assessed the impact of design thread count and duration of implantation on the
biocompatibility of the MFM in porcine animal models.
Methods: Eight mini-piglets received 26 MFM (12 with 56 thread design, 14 with
80 or 96 threads) in iliac, carotid, and renal arteries. Animals were sacriﬁced/
explanted at 1, 3, and 6 months, when histological and ultrastructural analyses
were conducted.
Results: The MFM was successfully deployed in 25 of 26 cases. Percentage ste-
nosis was 16.9%  5.1% for the 56 thread devices versus 33.4%  10.2% for the
80-96 thread devices (p ¼ 0.001) at 3 months, and 21.7%  9.9% for the 56 thread
devices versus 33.6%  12.4% for the 80-96 thread devices (p ¼ 0.004) at 6
months. The 5 devices selected for SEM examination were well deployed, inte-
grated into the vessel wall and endothelialized (Figure 1), and had patent side
branches.September 13–17, 2014 j TCT Abstracts/New Devices and Innovation
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMConclusions: The MFM integrated into the vessel wall while maintaining branch
patency over the course of the study. The 56 thread devices were well tolerated locally
and yielded fewer signs of inﬂammation and neointimal hyperplasia. Further pre-
clinical and clinical studies will extend assessment of the long-term safety and
effectiveness of the MFM.
TCT-440
Further Evolution In Aortic Arch Endografting
Sagi Raz1, Marcel Goodman2, Daniel Silverberg3, David Planer4
1Endospan, Hertzelia, Israel, 2University of Western Australia, Perth, Australia, 3The
Chaim Sheba Medical Center, Tel Hashomer, Israel, 4Hebrew University-Hadassah
Medical Center, Jerusalem, Israel
Background: Conventional surgical or hybrid repair of aortic arch aneurysms carries
substantial risk of mortality and morbidity. Early experience with custom made
branched arch endografts showed promising results, although availability and pro-
duction time limit their widespread use. Consequently, many patients remain
untreated.This preclinical study is the ﬁrst report of an off-the-shelf modular aortic
arch endograft, with a novel Z shape design addresses the unique procedural and long
term challenges with complete endovascular therapy for aortic arch pathologies.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/NeMethods: Sixteen pigs (7 acute, 9 chronic) underwent endovascular implantation of
the Nexus arch endograft over a brachio-iliac through & through wire technique,
with modular extensions to ascending aorta and LCC. Aggregate follow-up period was
481 days.
Results: Successful implantation of the modular graft was achieved in 100% of an-
imals. Mean procedural time was 9030 Min. Mean pressure gradient between
ascending aorta and cranial vessels was 02 mmHg. All chronic animals recovered
well. Long term follow up demonstrated no graft migration or side branch occlusion/
stenosis.
Conclusions: The novel designed arch endograft (see Figure) has the potential to
provide the next evolutionary step towards an off-the-shelf, pure endovascular
solution as a ﬁrst-line intervention for major aortic arch lesions. The integrated
brachial intra-procedural latching and Brachiocephalic artery placement of a
proximal (cranial) end of the main prosthesis provides the cornerstone for
increased intra-procedural and long term endograft ﬁxation. Initial clinical work
due Q3 2014.
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Background: As ablation and transseptal procedures become more common due to
the aging population, transseptal puncture complications become a larger concern.
Iatrogenic atrial septal defects (IASDs) are typically considered to close within a year
with 7% remaining at 12 months following a puncture with a 12 Fr catheter. Today,
IASDs are also attracting attention because cryoablation and MitraClip procedures
that use larger sheaths are common. The purpose of this experimental paradigm was to
characterize the biomechanical properties of the fossa ovalis in an animal model
commonly used for testing these procedures.
Methods: The atrial septa from Yorkshire Cross swine (n¼86) were excised for
experimentation. The inferior edge of the fossa ovalis was cut off for catheter
tear testing. Samples were randomized to 3 groups, and the transseptal punctures
were performed with a: 1) standard Brockenbrough needle, 2) Baylis RF needle,
or 3) custom RF 5 Fr needle, which was unique design in this study. More
speciﬁcally, catheter tear testing allows for the investigation of the resultant ef-
fects varying catheter sizes and different transseptal approaches have on inducing
trauma.
Results: We observed that the type of needle used for the transseptal puncture
had no statistically signiﬁcant effects on tear forces (p>0.05). This suggests that
on an acute time scale, the procedure a clinician utilized to cross the septum
could be one of personal preference, since no technology demonstrated an in-
crease in tear force and thus a reduction in IASD formation. Yet, there were
signiﬁcant differences in tearing the septum between different size sheaths (p<
0.05). Noteworthy, the forces required to initiate tearing in this study were
within the range of the forces able to be generated by clinically used catheter
and sheaths.
Conclusions: Tissue properties and their role in the formation of IASDs have not been
previously well studied. This suggests a need to improve our basic understanding in
how septa tearing arise and a means to minimize damage created during procedures.
This is the one of the ﬁrst studies performed to investigate a novel transseptal
approach in an effort to minimize IASD formation.
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Background: Polymer coatings of drug eluting stents (DES) have been shown to
offer a protective barrier against acute thrombus formation compared with bare metal
stents (BMS). While this anti-thrombotic function has been assigned to contempo-
rary DES utilizing permanent polymeric coatings, the impact of bioerodible poly-
meric coatings, strut thickness and fully bioresorbable scaffolds remains to be
determined.
Methods: A porcine ex vivo carotid to jugular arterio-venous shunt model
involving a test circuit of three in-line stents, was used to test thrombogenicity.
The Synergy stent (Boston Scientiﬁc) (n¼6) was compared to 3 different
stent types: 1) BioMatrix Flex (Biosensors) 2) BVS (Abbott), and 3)
OmegaTM (Boston Scientiﬁc) (n¼6 each). After 1h of circulation, platelet
adherence in whole mount stents was identiﬁed by immunoﬂuorescent staining
against dual platelet markers (CD61/CD42b) and quantiﬁed using confocal
microscopy.
Results: Synergy DES showed the least area occupied by thrombus compared to
the other 3 stents types, with a signiﬁcant difference compared to BioMatrix Flexw Devices and Innovation B129
